Trump endorses the use of CBD in a post

Summary

On Truth Social, President Trump urged officials to ‘properly and as quickly as possible’ advance access to Cannabidiol (CBD), citing its proven efficacy for many users Zhitong. This follows his December 2025 directive for federal agencies to loosen cannabis restrictions and expand CBD access for medical research .

Impact Analysis

So Trump is basically doubling down on his December directive to loosen the leash on CBD. By posting that we must move “as quickly as possible” for those who’ve felt its efficacy, he’s signaling a major shift from the usual federal foot-dragging Zhitong. This isn’t a pivot toward full recreational legalization; rather, it’s a tactical play on ‘medical freedom’ that appeals to a massive demographic of chronic pain sufferers and veterans while keeping his conservative base intact .

For the market, this is a significant de-risking event for hemp and CBD pure-plays. While his social media usually roils oil or crypto markets, this specific endorsement of ‘efficacy’ provides the regulatory cover the industry needs to scale CoinLive+ 2. The signal is clear: the executive branch is now an active tailwind for CBD access. Bottom line—the regulatory overhang is lifting. I’d be looking at high-quality CBD and hemp-focused equities as they move out of the gray zone and into a more formalized medical research framework.